Mycophenolic acid (MPA)

DRUG3 trials

Sponsors

Novartis, Novartis Pharmaceuticals, University Hospital, Angers

Conditions

Acute Myeloid Leukemia (AML)Graft RejectionKidney TransplantationRenal Transplant

Phase 2

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

RecruitingNCT02416388

University Hospital, AngersAcute Myeloid Leukemia (AML)

Start: 2015-01-31End: 2032-01-31Target: 3100Updated: 2024-08-07

Phase 3

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

CompletedNCT00251004

NovartisGraft Rejection, Kidney Transplantation

Start: 2005-10-31End: 2009-10-31Updated: 2011-05-10

Phase 4

24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients

CompletedNCT01169701

Novartis PharmaceuticalsRenal Transplant

Start: 2010-08-31End: 2014-03-31Updated: 2015-12-07

Related Papers

Impact of midostaurin in younger AML patients intensively treated with high-dose anthracycline

Blood2025-11-03

Frequency and impact of FLT3-ITD microclones in younger AML patients

Blood2025-11-03

Intermediate-Dose Cytarabine as Postinduction AML Therapy

NEJM Evidence2025-06-244 citations

Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network

Blood2024-11-054 citations

Sequential Intensified Conditioning Regimen Allogeneic Transplantation in Younger Adult Patients with Adverse-Risk Acute Myeloid Leukemia: A Multi-Center Prospective Study from the Acute Leukemia French Intergroup on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Blood2024-11-05

Cyclosporine <i>Versus</i> Cyclosporine Plus Mycophenolate Mofetil in Reduced Intensity Allogeneic Stem Cell Transplantation for Intermediate-Risk AML: A Multi-Center Randomized Study from the Acute Leukemia French Intergroup, on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Blood2024-11-05

Hyperleukocytosis Increases the Risk of Early Relapses Independently of Genetics in AML

Blood2023-11-021 citations

Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation

Transplant International2016-09-2020 citations